HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keith L Kirkwood Selected Research

Alveolar Bone Loss

1/2022Inhibition of acid sphingomyelinase by imipramine abolishes the synergy between metabolic syndrome and periodontitis on alveolar bone loss.
4/2020Acid sphingomyelinase deficiency exacerbates LPS-induced experimental periodontitis.
8/2019Activation of vitamin D in the gingival epithelium and its role in gingival inflammation and alveolar bone loss.
1/2019Functionalized nanoparticles containing MKP-1 agonists reduce periodontal bone loss.
1/2012MAPK usage in periodontal disease progression.
3/2011Silencing mitogen-activated protein kinase-activated protein kinase-2 arrests inflammatory bone loss.
10/2007A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model.
3/2007Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis.
1/2007A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keith L Kirkwood Research Topics

Disease

15Periodontal Diseases (Periodontal Disease)
01/2022 - 10/2005
12Inflammation (Inflammations)
01/2022 - 10/2008
10Neoplasms (Cancer)
01/2021 - 10/2005
9Alveolar Bone Loss
01/2022 - 01/2007
7Periodontitis
01/2022 - 10/2007
5Infections
08/2019 - 12/2003
5Squamous Cell Carcinoma of Head and Neck
12/2014 - 05/2008
4Bone Resorption
01/2015 - 05/2004
3Neoplasm Metastasis (Metastasis)
01/2020 - 10/2005
3Osteoarthritis
07/2012 - 10/2005
3Rheumatoid Arthritis
07/2012 - 10/2005
2Obesity
11/2021 - 10/2021
2Carcinogenesis
01/2020 - 05/2008
2Pathologic Processes
01/2020 - 10/2005
2Head and Neck Neoplasms (Head and Neck Cancer)
05/2014 - 03/2013
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1Insulin Resistance
01/2022
1Niemann-Pick Diseases (Niemann Pick Disease)
04/2020
1Stomatognathic Diseases (Dental Disease)
01/2018
1Wounds and Injuries (Trauma)
01/2018
1Body Weight (Weight, Body)
02/2012
1Osteolysis
08/2009
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2008
1Aggressive Periodontitis (Periodontosis)
03/2007

Drug/Important Bio-Agent (IBA)

16CytokinesIBA
01/2022 - 01/2007
8LipopolysaccharidesIBA
01/2022 - 01/2007
7p38 Mitogen-Activated Protein KinasesIBA
12/2014 - 01/2007
5ChemokinesIBA
01/2021 - 07/2012
5thiamine triphosphorate (TTP)IBA
05/2014 - 10/2008
4Biological ProductsIBA
10/2021 - 01/2018
4Mitogen-Activated Protein KinasesIBA
01/2020 - 01/2007
4Proteins (Proteins, Gene)FDA Link
12/2014 - 05/2008
3Interleukin-6 (Interleukin 6)IBA
03/2013 - 05/2004
3TristetraprolinIBA
01/2012 - 10/2008
2Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
01/2022 - 04/2020
2AcidsIBA
01/2022 - 04/2020
2CeramidesIBA
01/2022 - 04/2020
2RNA (Ribonucleic Acid)IBA
08/2019 - 01/2012
2Messenger RNA (mRNA)IBA
12/2014 - 10/2008
2Protein Kinases (Protein Kinase)IBA
08/2013 - 03/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2012 - 06/2011
2Biomarkers (Surrogate Marker)IBA
06/2011 - 05/2008
1Tartrate-Resistant Acid PhosphataseIBA
01/2022
1Palmitic Acid (Hexadecanoic Acid)IBA
01/2022
1Imipramine (Janimine)FDA LinkGeneric
01/2022
1Nonesterified Fatty Acids (NEFA)IBA
01/2022
1CholesterolIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1CarbohydratesIBA
01/2022
1salicylhydroxamic acid (SHAM)IBA
11/2021
1SphingomyelinsIBA
04/2020
1SphingolipidsIBA
04/2020
1Vitamin DFDA LinkGeneric
08/2019
1hydroxide ionIBA
08/2019
1Cholecalciferol (Vitamin D3)FDA Link
08/2019
1Mitogen-Activated Protein Kinase PhosphatasesIBA
01/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2014
1SB 203580IBA
12/2014
1Type 2 Galanin ReceptorIBA
05/2014
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2014
1MitogensIBA
08/2013
1LuciferasesIBA
02/2013
1CurcuminIBA
02/2012
1Small Interfering RNA (siRNA)IBA
01/2012
1Complement System Proteins (Complement)IBA
11/2011
1Protein Phosphatase 1IBA
11/2011
1ImmunosorbentsIBA
06/2011
1Prostaglandins EIBA
06/2011
1Dinoprostone (PGE2)FDA Link
06/2011
1EnzymesIBA
06/2011
1transcription factor NF-AT c3IBA
08/2009
1RANK LigandIBA
08/2009
1RNA-Binding Proteins (RNA-Binding Protein)IBA
10/2008
1Matrix Metalloproteinases (MMPs)IBA
05/2008
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2008
1Matrix Metalloproteinase 13IBA
10/2005
1Clindamycin (Cleocin)FDA LinkGeneric
12/2003
1Penicillins (Penicillin)FDA Link
12/2003
1Anti-Bacterial Agents (Antibiotics)IBA
12/2003
1Azithromycin (Zithromax)FDA LinkGeneric
12/2003
1Pharmaceutical PreparationsIBA
12/2003
1MacrolidesIBA
12/2003

Therapy/Procedure

3Therapeutics
01/2019 - 01/2018
1Diet Therapy (Therapy, Diet)
08/2019
1Subcutaneous Injections
12/2014
1Reoperation
07/2012
1Injections
10/2007